PETALING JAYA, Malaysia, Jan 9, 2023 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a number one genomics and biopharmaceutical specialist, is satisfied to roar a strategic cooperation with SIRIM Berhad, to search out the commercialisation of joint analysis and increase (R&D) initiatives within the clinical and biotechnology fields.
Encik Sasha Nordin, Chief Executive Officer of Malaysian Genomics
SIRIM Berhad is wholly owned by the Malaysian Executive, and is centered on R&D, standardisation and quality. The organisation acts as a catalyst for industrial increase via programmes appealing technology and standardisation.Below the strategic cooperation, each events will review the functionality industrial label of a range of genomics-driven biotechnology R&D initiatives. These encompass rising biofuels and biopharmaceuticals, accomplice diagnostic assessments for most cancers therapy, and bioactive cosmeceuticals.
Encik Sasha Nordin, Chief Executive Officer of Malaysian Genomics, mentioned, “SIRIM and Malaysian Genomics include complementary experiences, resources, and technology property. Teams from each organisations include met to search out their analysis and form interests in precision treatment, food security, and products for the user market. This strategic collaboration will pave the vogue for particular individual agreements reveal to initiatives for which industrial alternatives had been acknowledged.”
President and Team Chief Executive Officer of SIRIM Berhad, Dato’ Indera Dr Ahmad Sabirin Arshad mentioned, “We scrutinize forward to working carefully with Malaysian Genomics on R&D initiatives that can wait on the nation and home industries. This strategic collaboration will expedite the relevant processes to create sure each events can detect the industrial viability of initiatives, sooner than taking off analysis, increase and commercialisation.”
The events of this two-year strategic collaboration will additionally collectively offer for factual interior most and public institutional partners for the funding and commercialisation of these initiatives.
Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
Topic: Press release summary
Source: Malaysian Genomics Resource Centre Berhad
Sectors: Day-to-day Finance, Day-to-day Files, BioTech, Healthcare & Pharm, Native Biz
From the Asia Company Files Network
Copyright © 2023 ACN Newswire. All rights reserved. A division of Asia Company Files Network.